Trademark: 76365742
Word
GENFIT
Status
Registered
Status Code
800
Status Date
Friday, March 29, 2024
Serial Number
76365742
Registration Number
2865973
Registration Date
Tuesday, July 27, 2004
Mark Type
1000
Filing Date
Thursday, January 31, 2002
Published for Opposition
Tuesday, May 4, 2004

Trademark Owner History
GENFIT - Original Registrant

Classifications
5 Pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, infections, cancers and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes;[ veterinary pharmaceutical preparations for use in the treatment of cardiovascular diseases, dermatological diseases, metabolic disorders, inflammatory disorders, skin and mucosal disorders, disorders in the central nervous system, cancers, and oncological disorders, immunodeficiency and immunologic disorders, asthma, allergies, lipidic disorders, obesity and diabetes; sanitary preparations for diagnosis and for acute and chronic care, namely, antibiotic, antibacterial, antiviral and antifungal agents for elimination or reduction of germs, bacteria, viruses and fungi;] chemical preparations for medical, pharmaceutical or[ veterinary] diagnostic use; enzymatic preparations for medical, pharmaceutical [or veterinary] use; biological preparations, namely, antibodies and fragments of antibodies for laboratories, diagnostics, and analytics for human[ and veterinary] medical diagnostic use; pharmaceutical preparations for the treatment of skin conditions, [medicated skin care preparation for pharmaceutical use; medicated sunburn preventing products, namely, creams, oils, lotions, gels, for pharmaceutical use; slimming medical preparations;] cultures of microorganisms for medical, pharmaceutical [and veterinary ]use; media for bacteriological cultures; nutrients for use in medical, pharmaceutical [and veterinary research;] cell preparations for medical, pharmaceutical [or veterinary use,] in particular for gene therapy and cell therapy; [kits consisting primarily of culture media, culture boxes, culture additives, and diagnostic reagents for the preparation of cells or for the selection of biologically active compounds for medical, pharmaceutical or veterinary laboratory testing, or for medical or veterinary diagnostic use; diagnostic and biological preparations and cultures of microorganisms and cells for clinical or medical laboratory use; reagents for medical, veterinary and diagnostic use, diagnosis products, namely,] reagents for medical [or veterinary use;] chemical and biological reagents for clinical or medical laboratory use;[ diagnostic preparations for clinical or medical laboratory use;] diagnosis reagents for medical[, veterinary] use[ and in vitro use in biochemistry,] clinical chemistry and microbiology[; dietetic substances, namely, dietary supplements and food supplements for medical use; dietetic foodstuffs adapted for medical use]
44 Providing an online electronic computer database in the field of medical and pharmaceutical information
42 Pharmaceutical research and development of new drug products for others; scientific, biological and medical research in the fields of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development of new drug products for others; scientific, biological and medical research in the field of pharmacology, analytical chemistry, biological and medical research in the field of pharmacology, analytical chemistry, biochemistry, immunology, genetic, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, chemical, biochemical and biotechnological analysis; basic and applied scientific research; technical research, namely screening and selection of molecules; validation of biological targets; development and validation of biological tests, cell tests, and genetic tests, identifying, characterizing, validating, and development biologically active molecules through the se of functional genomics; analysis of biological substances in biological fluids; technical consultation in the field of pharmaceuticals; legal services in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research, medical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research and for the pharmaceutical industry; surveying and engineering; chemical analysis in the field of pharmacology; technical consultation in the field of pharmacology; consultation, not connected with the conduct of business, in the fields of scientific research and therapy; research and development of new pharmaceutical products for third parties; providing an online electronic computer database in the field of scientific information
Color is not claimed as a feature of the mark.

Trademark Events
Mar 29, 2024
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Mar 29, 2024
Registered And Renewed (Second Renewal - 10 Yrs)
Mar 29, 2024
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 29, 2024
Case Assigned To Post Registration Paralegal
Nov 6, 2023
Teas Section 8 & 9 Received
Jul 27, 2023
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 16, 2014
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Sep 16, 2014
Registered And Renewed (First Renewal - 10 Yrs)
Sep 16, 2014
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Aug 13, 2014
Case Assigned To Post Registration Paralegal
Jul 25, 2014
Teas Section 8 & 9 Received
Aug 13, 2010
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Aug 11, 2010
Case Assigned To Post Registration Paralegal
Jul 22, 2010
Teas Section 8 & 15 Received
Feb 20, 2009
Review Of Correspondence Complete
Feb 2, 2009
Paper Received
Jul 27, 2004
Registered-Principal Register
May 10, 2004
Paper Received
May 4, 2004
Published For Opposition
Apr 14, 2004
Notice Of Publication
Dec 2, 2003
Approved For Pub - Principal Register
Oct 16, 2003
Correspondence Received In Law Office
Oct 20, 2003
Paper Received
Aug 27, 2003
Non-Final Action Mailed
Jul 9, 2003
Sec. 1(B) Claim Deleted
Jul 9, 2003
Correspondence Received In Law Office
Jul 9, 2003
Paper Received
Jul 16, 2003
Case File In Ticrs
Jan 10, 2003
Letter Of Suspension Mailed
Nov 8, 2002
Correspondence Received In Law Office
Nov 13, 2002
Correspondence Received In Law Office
Nov 13, 2002
Paper Received
Oct 17, 2002
Assigned To Examiner
Apr 29, 2002
Paper Received
May 8, 2002
Non-Final Action Mailed
Apr 19, 2002
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24